Items where authors include "De Luca, G."

Article

De Lorenzis, E., Natalello, G., Pellegrino, G. et al. (29 more authors) (2024) Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life. Rheumatology. keae532. ISSN 1462-0324

Avanoglu-Guler, A. orcid.org/0000-0001-9866-9797, Campochiaro, C., De Luca, G. et al. (6 more authors) (2024) Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients’ hands. Seminars in Arthritis and Rheumatism, 66. 152431. ISSN 0049-0172

Deibel, E. orcid.org/0000-0003-4652-9826, Carreira, P.E., Vonk, M. orcid.org/0000-0002-2266-9907 et al. (61 more authors) (2024) Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time? Arthritis Care & Research, 76 (1). pp. 88-97. ISSN 2151-464X

Kalincik, T., Sharmin, S., Roos, I. et al. (150 more authors) (2023) Comparative effectiveness of autologous hematopoietic stem cell transplant vs fingolimod, natalizumab, and ocrelizumab in highly active relapsing-remitting multiple sclerosis. JAMA Neurology, 80 (7). pp. 702-713. ISSN 2168-6149

Garaiman, A., Steigmiller, K., Gebhard, C. et al. (171 more authors) (2023) Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model. Rheumatology, 62 (SI). SI91-SI100. ISSN 1462-0324

Campochiaro, C. orcid.org/0000-0001-6806-3794, Hoffmann-Vold, A.-M. orcid.org/0000-0001-6467-7422, Avouac, J. et al. (90 more authors) (2022) Sex influence on outcomes of patients with systemic sclerosis–associated interstitial lung disease: a EUSTAR database analysis. Rheumatology, 62 (7). pp. 2483-2491. ISSN 1462-0324

Lazzaroni, M-G., Marasco, E., Campochiaro, C. et al. (30 more authors) (2021) The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort. Rheumatology, 60 (11). pp. 5028-5041. ISSN 1462-0324

Conference or Workshop Item

Campochiaro, C., Mongin, D., Courvoisier, D.S. et al. (16 more authors) (2025) OP0082 Evidence-based detection of progression of systemic sclerosis-interstitial lung disease patients: the EUSTAR-PPF study (CP number 148). In: EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain.

Verardi, L., De Lorenzis, E., Pellegrino, G. et al. (19 more authors) (2023) POS1324 mycophenolate mofetil use in clinical practice in a multicentric cohort of scleroderma patients: persistence on therapy and long-term adverse events. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

Proceedings Paper

Campochiaro, C., Mongin, D., Courvoisier, D.S. et al. (16 more authors) (2025) OP0082 Evidence-based detection of progression of systemic sclerosis-interstitial lung disease patients: the EUSTAR-PPF study (CP number 148). In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. Elsevier , pp. 72-73.

Guler, A.A., Hughes, M., De Luca, G. et al. (17 more authors) (2025) OP0219 CLINICAL CHARACTERISTICS AND RISK FACTORS FOR CALCINOSIS CUTIS IN SYSTEMIC SCLEROSIS: INSIGHTS FROM THE EUROPEAN SCLERODERMA TRIAL AND RESEARCH GROUP (EUSTAR) DATABASE. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. BMJ Publishing Group , pp. 183-184.